Market Overview:
The global lipids for pharmaceutical fields market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for lipid-based drugs and rising prevalence of lifestyle diseases. The global lipids for pharmaceutical fields market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into triglycerides, phospholipids, sphingolipids, cholesterol, fatty acids, and others. Triglycerides are expected to account for a major share of the global lipids for pharmaceutical fields market in 2018 owing to their high demand as ingredients in drug formulations. Phospholipids are also anticipated to witness significant growth during the forecast period due to their various applications in drug formulations such as oral suspensions and emulsions. On the basis of application,the global lipids for pharmaceuticals fieldsmarket is divided into three segments:pharmaceutical companies; health product companies;and others (including contract research organizations [CROs], contract manufacturing organizations [CMOs], academic institutions/research institutes). Pharmaceutical companies held a dominant shareof over 60%in 2017 owingto their large-scale production capabilitiesand growing demandfor lipid-baseddrugs acrossthe globe .
Product Definition:
Lipids are organic molecules that include fats, waxes, sterols and fat-soluble vitamins. Lipids are important in the pharmaceutical field because they can be used to create drug delivery systems. By encapsulating drugs in lipid particles, the drugs can be delivered to specific parts of the body. This is important because it allows for more targeted drug therapy and less systemic side effects.
Triglycerides:
Triglycerides are lipids that are found in the blood and other body fluids. They are formed during fat digestion and can also be manufactured by the body. Triglycerides help maintain blood glucose levels, protect cell membranes, enhance immune function & assist in healing tissues.
Phospholipids:
Phospholipids are lipoprotein particles that are majorly used as a building block for the formulation of various pharmaceutical products. They can be extracted from animal and vegetable sources. Phospholipids have wide applications in the food industry as additives, emulsifiers, stabilizers, and thickening agents. The growing demand for phospholipid-based ingredients in dietary supplements is expected to drive market growth over the forecast period.
Application Insights:
Pharmaceutical company was the largest application segment in 2017 and accounted for more than 50% of market share. Pharmaceutical companies use lipids to manufacture medicines, which are used in the treatment of various diseases such as cardiovascular, neurological, diabetes and cancer. The growing usage of specialty pharmaceuticals is expected to be a key factor driving product demand over the forecast period.
Health product company is anticipated to be one of the fastest-growing segments during the forecast period owing to rising consumer awareness regarding health benefits associated with consumption of natural products like essential fatty acids and herbal supplements containing these ingredients. For instance, herbs contain anti-inflammatory omega 3 fatty acid that reduces heart disease by reducing bad cholesterol levels in blood & lowering blood pressure etc., Rising demand for naturally derived pharmaceutical products will drive this segment over next few years.
Other applications include cosmetics.
Regional Analysis:
North America dominated the global market in 2017, with a revenue share of over 35.0%. This is attributed to the presence of major pharmaceutical companies and increasing R&D activities for new drug development. Moreover, growing demand for nutraceuticals and cosmetics products is also expected to drive growth during the forecast period. Asia Pacific region is anticipated to witness lucrative growth over the coming years owing to rising healthcare expenditure by governments as well as private sectors in order to improve public health system along with rising awareness about preventive medicine among people living in this region. Increasing prevalence of diabetes, cardiovascular diseases (CVD), cancer, etc., are some other factors contributing toward regional growth. In addition, favorable government policies such as “Make in India†initiative by Indian government are expected favorably impact regional market during forecast period (2018-2030).
Moreover, Latin America has also been witnessing significant developments due its geographical location between two major markets; North America.
Growth Factors:
- Increasing demand for lipid-based drugs and therapies
- Growing prevalence of chronic diseases that require lipid-based treatments
- Advances in lipid-based drug delivery technologies
- Rising research and development investments in the field of lipids for pharmaceuticals
- Growing awareness about the benefits of lipid-based drugs and therapies
Scope Of The Report
Report Attributes
Report Details
Report Title
Lipids for Pharmaceutical Fields Market Research Report
By Type
Triglycerides, Phospholipids, Sphingolipids, Cholesterol, Fatty Acids
By Application
Pharmaceutical Company, Health Product Company, Others
By Companies
Merck, CordenPharma, DSM, Nippon Fine Chemical Co.,Ltd, Abitec Corp., Larodan, BASF (Pronova Biopharma), ADM, Cerbios-Pharma SA, Jiangsu Maxim, Shanghai Taiwei, Shanghai AVT, Nanjing Luye Pharmaceutical Co.,Ltd, LIPOID, NOF Corporation, Dishman Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
145
Number of Tables & Figures
102
Customization Available
Yes, the report can be customized as per your need.
Global Lipids for Pharmaceutical Fields Market Report Segments:
The global Lipids for Pharmaceutical Fields market is segmented on the basis of:
Types
Triglycerides, Phospholipids, Sphingolipids, Cholesterol, Fatty Acids
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical Company, Health Product Company, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- CordenPharma
- DSM
- Nippon Fine Chemical Co.,Ltd
- Abitec Corp.
- Larodan
- BASF (Pronova Biopharma)
- ADM
- Cerbios-Pharma SA
- Jiangsu Maxim
- Shanghai Taiwei
- Shanghai AVT
- Nanjing Luye Pharmaceutical Co.,Ltd
- LIPOID
- NOF Corporation
- Dishman Group
Highlights of The Lipids for Pharmaceutical Fields Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Triglycerides
- Phospholipids
- Sphingolipids
- Cholesterol
- Fatty Acids
- By Application:
- Pharmaceutical Company
- Health Product Company
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Lipids for Pharmaceutical Fields Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Lipids are molecules that consist of a fatty acid and a glycerol backbone. They play an important role in the body, providing energy for cells and helping to form cell membranes. Lipids are also used as pharmaceuticals because they can cross the blood-brain barrier, which is why they are often used in drugs that treat conditions like Alzheimer's disease or dementia.
Some of the major companies in the lipids for pharmaceutical fields market are Merck, CordenPharma, DSM, Nippon Fine Chemical Co.,Ltd, Abitec Corp., Larodan, BASF (Pronova Biopharma), ADM, Cerbios-Pharma SA, Jiangsu Maxim, Shanghai Taiwei, Shanghai AVT, Nanjing Luye Pharmaceutical Co.,Ltd, LIPOID, NOF Corporation, Dishman Group.
The lipids for pharmaceutical fields market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Lipids for Pharmaceutical Fields Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Lipids for Pharmaceutical Fields Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Lipids for Pharmaceutical Fields Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Lipids for Pharmaceutical Fields Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Lipids for Pharmaceutical Fields Market Size & Forecast, 2018-2028
4.5.1 Lipids for Pharmaceutical Fields Market Size and Y-o-Y Growth
4.5.2 Lipids for Pharmaceutical Fields Market Absolute $ Opportunity
Chapter 5 Global Lipids for Pharmaceutical Fields Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Lipids for Pharmaceutical Fields Market Size Forecast by Type
5.2.1 Triglycerides
5.2.2 Phospholipids
5.2.3 Sphingolipids
5.2.4 Cholesterol
5.2.5 Fatty Acids
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Lipids for Pharmaceutical Fields Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Lipids for Pharmaceutical Fields Market Size Forecast by Applications
6.2.1 Pharmaceutical Company
6.2.2 Health Product Company
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Lipids for Pharmaceutical Fields Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Lipids for Pharmaceutical Fields Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Lipids for Pharmaceutical Fields Analysis and Forecast
9.1 Introduction
9.2 North America Lipids for Pharmaceutical Fields Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Lipids for Pharmaceutical Fields Market Size Forecast by Type
9.6.1 Triglycerides
9.6.2 Phospholipids
9.6.3 Sphingolipids
9.6.4 Cholesterol
9.6.5 Fatty Acids
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Lipids for Pharmaceutical Fields Market Size Forecast by Applications
9.10.1 Pharmaceutical Company
9.10.2 Health Product Company
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Lipids for Pharmaceutical Fields Analysis and Forecast
10.1 Introduction
10.2 Europe Lipids for Pharmaceutical Fields Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Lipids for Pharmaceutical Fields Market Size Forecast by Type
10.6.1 Triglycerides
10.6.2 Phospholipids
10.6.3 Sphingolipids
10.6.4 Cholesterol
10.6.5 Fatty Acids
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Lipids for Pharmaceutical Fields Market Size Forecast by Applications
10.10.1 Pharmaceutical Company
10.10.2 Health Product Company
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Lipids for Pharmaceutical Fields Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Lipids for Pharmaceutical Fields Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Lipids for Pharmaceutical Fields Market Size Forecast by Type
11.6.1 Triglycerides
11.6.2 Phospholipids
11.6.3 Sphingolipids
11.6.4 Cholesterol
11.6.5 Fatty Acids
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Lipids for Pharmaceutical Fields Market Size Forecast by Applications
11.10.1 Pharmaceutical Company
11.10.2 Health Product Company
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Lipids for Pharmaceutical Fields Analysis and Forecast
12.1 Introduction
12.2 Latin America Lipids for Pharmaceutical Fields Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Lipids for Pharmaceutical Fields Market Size Forecast by Type
12.6.1 Triglycerides
12.6.2 Phospholipids
12.6.3 Sphingolipids
12.6.4 Cholesterol
12.6.5 Fatty Acids
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Lipids for Pharmaceutical Fields Market Size Forecast by Applications
12.10.1 Pharmaceutical Company
12.10.2 Health Product Company
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Lipids for Pharmaceutical Fields Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Lipids for Pharmaceutical Fields Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Lipids for Pharmaceutical Fields Market Size Forecast by Type
13.6.1 Triglycerides
13.6.2 Phospholipids
13.6.3 Sphingolipids
13.6.4 Cholesterol
13.6.5 Fatty Acids
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Lipids for Pharmaceutical Fields Market Size Forecast by Applications
13.10.1 Pharmaceutical Company
13.10.2 Health Product Company
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Lipids for Pharmaceutical Fields Market: Competitive Dashboard
14.2 Global Lipids for Pharmaceutical Fields Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 CordenPharma
14.3.3 DSM
14.3.4 Nippon Fine Chemical Co.,Ltd
14.3.5 Abitec Corp.
14.3.6 Larodan
14.3.7 BASF (Pronova Biopharma)
14.3.8 ADM
14.3.9 Cerbios-Pharma SA
14.3.10 Jiangsu Maxim
14.3.11 Shanghai Taiwei
14.3.12 Shanghai AVT
14.3.13 Nanjing Luye Pharmaceutical Co.,Ltd
14.3.14 LIPOID
14.3.15 NOF Corporation
14.3.16 Dishman Group
